Coronary artery disease (CAD) is the most frequent cause of death globally and the most common cause of heart failure (HF) in resource-abundant countries.
1-5 The incidence of systolic myocardial dysfunction is increasing among patients with CAD in part because of improved survival after acute myocardial infarction (MI).
5 However, the long-term prognosis for this condition remains poor.
6,7